Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | protein kinase, putative | 0.0711 | 0.026 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Loa Loa (eye worm) | AGC/DMPK/GEK protein kinase | 0.0711 | 0.026 | 0.0327 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.1319 | 0.1782 | 0.1782 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1319 | 0.1782 | 0.1782 |
Schistosoma mansoni | serine/threonine kinase | 0.0711 | 0.026 | 0.026 |
Echinococcus multilocularis | telomerase reverse transcriptase subunit | 0.3282 | 0.6697 | 0.6697 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S10 | 0.2245 | 0.4101 | 1 |
Brugia malayi | Serine carboxypeptidase F41C3.5 precursor | 0.2245 | 0.4101 | 0.4803 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0711 | 0.026 | 0.026 |
Brugia malayi | protein kinase C II. | 0.1319 | 0.1782 | 0.1903 |
Loa Loa (eye worm) | AGC/PKN protein kinase | 0.0711 | 0.026 | 0.0327 |
Echinococcus granulosus | NDR protein kinase | 0.0711 | 0.026 | 0.026 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0711 | 0.026 | 0.026 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.0711 | 0.026 | 0.026 |
Loa Loa (eye worm) | hypothetical protein | 0.2245 | 0.4101 | 0.5154 |
Entamoeba histolytica | protein kinase, putative | 0.0711 | 0.026 | 0.5 |
Brugia malayi | Protein kinase c protein 2 | 0.3905 | 0.8257 | 1 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S10 | 0.2245 | 0.4101 | 1 |
Trypanosoma cruzi | serine carboxypeptidase (CBP1), putative | 0.2245 | 0.4101 | 0.5 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S10, putative | 0.2245 | 0.4101 | 0.5 |
Loa Loa (eye worm) | AGC/NDR protein kinase | 0.0711 | 0.026 | 0.0327 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Loa Loa (eye worm) | AGC/RSK/MSK protein kinase | 0.0711 | 0.026 | 0.0327 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0711 | 0.026 | 0.0327 |
Schistosoma mansoni | serine/threonine protein kinase | 0.4601 | 1 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0711 | 0.026 | 0.026 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0711 | 0.026 | 0.026 |
Schistosoma mansoni | family S10 non-peptidase homologue (S10 family) | 0.2245 | 0.4101 | 0.4101 |
Echinococcus multilocularis | ribosomal protein s6 kinase beta 1 | 0.0711 | 0.026 | 0.026 |
Loa Loa (eye worm) | hypothetical protein | 0.3282 | 0.6697 | 0.8417 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S10 | 0.2245 | 0.4101 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0711 | 0.026 | 0.026 |
Entamoeba histolytica | protein kinase, putative | 0.0711 | 0.026 | 0.5 |
Onchocerca volvulus | Uncharacterized serine carboxypeptidase homolog | 0.2245 | 0.4101 | 1 |
Echinococcus multilocularis | RNA directed DNA polymerase | 0.3282 | 0.6697 | 0.6697 |
Echinococcus granulosus | family S10 non peptidase ue S10 family | 0.2023 | 0.3545 | 0.3545 |
Echinococcus granulosus | ribosomal protein S6 kinase alpha 3 | 0.0711 | 0.026 | 0.026 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0711 | 0.026 | 0.0327 |
Trypanosoma cruzi | serine carboxypeptidase (CBP1), putative | 0.2245 | 0.4101 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.1319 | 0.1782 | 0.2239 |
Echinococcus multilocularis | Ribosomal protein S6 kinase beta 2 | 0.0711 | 0.026 | 0.026 |
Loa Loa (eye worm) | hypothetical protein | 0.3785 | 0.7957 | 1 |
Leishmania major | serine carboxypeptidase (CBP1), putative,serine peptidase, Clan SC, Family S10 | 0.2245 | 0.4101 | 0.5 |
Schistosoma mansoni | family S10 unassigned peptidase (S10 family) | 0.2245 | 0.4101 | 0.4101 |
Echinococcus multilocularis | serine:threonine protein kinase 38 | 0.0711 | 0.026 | 0.026 |
Echinococcus multilocularis | family S10 non peptidase ue (S10 family) | 0.2023 | 0.3545 | 0.3545 |
Echinococcus multilocularis | lysosomal protective protein | 0.2245 | 0.4101 | 0.4101 |
Echinococcus granulosus | lysosomal protective protein | 0.2245 | 0.4101 | 0.4101 |
Echinococcus granulosus | RNA directed DNA polymerase | 0.3282 | 0.6697 | 0.6697 |
Echinococcus multilocularis | ribosomal protein S6 kinase alpha 3 | 0.0711 | 0.026 | 0.026 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Echinococcus granulosus | Ribosomal protein S6 kinase beta 2 | 0.0711 | 0.026 | 0.026 |
Echinococcus multilocularis | serine threonine protein kinase | 0.4098 | 0.874 | 0.874 |
Schistosoma mansoni | serine/threonine protein kinase | 0.4601 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0711 | 0.026 | 0.5 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.3402 | 0.6997 | 0.8794 |
Loa Loa (eye worm) | AGC/RSK/RSK protein kinase | 0.0711 | 0.026 | 0.0327 |
Toxoplasma gondii | AGC kinase | 0.0711 | 0.026 | 0.5 |
Echinococcus multilocularis | protein kinase c iota type | 0.1214 | 0.152 | 0.152 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S10, putative | 0.2245 | 0.4101 | 0.5 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.4601 | 1 | 1 |
Echinococcus granulosus | protein kinase c epsilon type | 0.1319 | 0.1782 | 0.1782 |
Echinococcus granulosus | ribosomal protein s6 kinase beta 1 | 0.0711 | 0.026 | 0.026 |
Trichomonas vaginalis | AGC family protein kinase | 0.0711 | 0.026 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0711 | 0.026 | 0.026 |
Echinococcus granulosus | protein kinase c iota type | 0.1214 | 0.152 | 0.152 |
Loa Loa (eye worm) | hypothetical protein | 0.0711 | 0.026 | 0.0327 |
Schistosoma mansoni | atypical protein kinase C | 0.1214 | 0.152 | 0.152 |
Echinococcus granulosus | protein kinase C gamma type | 0.4098 | 0.874 | 0.874 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.829 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.816 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.782 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.761 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.758 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.733 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.671 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.